The European Federation for Medicinal Chemistry (EFMC) is an independent association founded in 1970 that represents 25 scientific organisations from 23 European countries. Its objective is to advance the science of medicinal chemistry by promoting cooperation and encouraging strong links between the national adhering organisations in order to deepen contacts and exchanges between medicinal chemists in Europe and around the World. EFMC fulfils this objective by organizing symposia and short courses, by sponsoring meetings and medicinal chemistry schools, by publishing on relevant topics and by conferring awards and prizes.
Its most important organisation is the biennial International Symposium on Medicinal Chemistry (EFMC-ISMC). These symposia, with an average attendance of 1,200 delegates, are highly international with a broad range of speakers and attendees from the pharmaceutical industry and academia. Next to the ISMC, EFMC is involved in the organisation of the Frontiers in Medicinal Chemistry (FMC) and the international symposium on Advances in Synthetic and Medicinal Chemistry (ASMC). EFMC also organises intensive short courses on specific topics in medicinal chemistry.
An important part of the EFMC activities is sponsorship of national scientific meetings and Medicinal Chemistry Schools. EFMC also awards travel grants for younger scientists to attend EFMC symposia and schools.
Furthermore, in collaboration with the Royal Society of Chemistry, EFMC is publishing MedChemComm, the official journal of EFMC. MedChemComm is a peer reviewed journal publishing concise articles and reviews covering medicinal chemistry research. The electronic newsletter MedChemWatch as well as the yearbook “Medicinal Chemistry in Europe” help to further develop contacts between medicinal chemists around the world.
EFMC also acknowledges the excellence of medicinal chemists’ work, by conferring three major awards: the Nauta Award on Pharmacochemistry, the UCB-Ehrlich Award for Excellence in Medicinal Chemistry and the Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery, which are given every two years for outstanding achievements in the field of Medicinal Chemistry. From 2010 on, EFMC established two new prizes to acknowledge the scientific accomplishments of young medicinal chemists, both in industry and academia.
The objective of the EFMC is to advance the science of medicinal chemistry by promoting cooperation between the adhering organisations.
EFMC persues this objective in the following manner:
- By holding (or assisting in the holding of) the biennial International Symposium on Medicinal Chemistry (EFMC-ISMC) and other scientific meetings or schools, exchanging ideas and informations, by offering opportunities and by encouraging discussion related to medicinal chemistry.
- By editing “Medicinal Chemistry in Europe” the EFMC Yearbook which is aiming to become a reference handbook dedicated to medicinal chemistry, giving not only national societies but also corporate companies involved in medicinal chemistry the opportunity to dispatch their dynamic profile and image amongst medicinal scientists.
- By cooperating with other international scientific organisations (e.g. ACS,AFMC, EuCheMS, Eufeps, IUPAC etc.) and by collaborating with other societies in joint meetings.
- By establishing working-groups for studying subjects related to medicinal chemistry.
- By conferring awards including the Nauta Award for Pharmacochemistry, established by the Dutch Foundation “Stichting Prof. Dr.W.Th. Nauta Fonds”, the UCB-Ehrlich Award for Excellence in Medicinal Chemistry, established by the Belgian UCB S.A., Pharma Sector, and the Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery, established by the Prous Science S.A.
- By conferring the EFMC Prize for a Young Medicinal Chemist in Industry and the EFMC Prize for a Young Medicinal Chemist in Academia. The Prizes are given annually and consist of a diploma, €1000 and an invitation for a short presentation at an EFMC organised symposium.
- By publishing the Proceedings of the EFMC-ISMC.
- Regulations of the EFMC
MedChemComm was launched in mid 2010 as the EFMC journal, published by the Royal Society of Chemistry. MedChemComm is released monthly and contains scientific work of the highest quality in all the fields of medicinal chemistry
MedChemWatch is the newsletter of EFMC, launched in 2008. In its current format, it is released quarterly and publishes news and events from the EC, committees, and member societies. In addition, a perspective article and a lab presentation from leading groups in medicinal chemistry complete the format of the newsletter.
The EFMC Yearbook “Medicinal Chemistry in Europe” is published yearly by EFMC since 2002 to give an overview of medicinal chemistry in Europe in general.